Oral delta-9-tetrahydracannabinol (Δ9-THC) and palmitoylethanolamide (PEA), in a proprietary combination known as THX-110, is promising for reducing tic symptoms in adults with Tourette syndrome (TS), new research suggests. In a small phase 2 trial, investigators administered THX-110 to 16 adults…